Navigation Links
BAXL Technologies Partners With Epikinonia at Maternity Clinic in Athens, Greece
Date:12/19/2007

Director of Epikinonia Ltd said, "Greek health care has always had an eye toward innovation. Clinics are looking to educate their patients, track patients and personnel within the facility, and manage records and prescriptions through the same infrastructure being used for HSIA and entertainment video services. BAXL has the most innovative products to accomplish this in the market today."

About BAXL Technologies

BAXL Technologies, Inc. is a solutions provider enabling the reliable delivery of wired and wireless broadband applications including voice, video and data, over any existing wiring. BAXL's customers include many of the world's leading hotels, as well as multiple tenant properties and is marketed and sold through telecom, cable, satellite and technology providers. For more information please visit http://www.baxl.net.

About Epikinonia Ltd.

Epikinonia (EPI), headquartered in Greece, specializes in full system integration including: Software Development; Integrated Solutions with Wired, Wireless, Satellite Networks; Integrated Solutions for modern infrastructure Hotels, Hospitals, Large Buildings, to access the Internet, IPTV, BMS, and Signage; IP Surveillance, image analysis, and performance statistics. For more information please visit http://www.epi.com.gr.

Contact:

Allen & Caron BAXL Technologies

(212) 691-8087 (203) 730-1791

Rudy Barrio (US Investors) Media Contact:

r.barrio@allencaron.com Jeffrey Romano

Director of Marketing

Brian Kennedy (US Media) jromano@baxl.net

brian@allencaron.com


'/>"/>
SOURCE BAXL Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
2. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
3. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
4. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
5. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
6. Advanced technologies aim to transform the coaching of top athletes
7. Global Med Technologies(R) Extends Its Worldwide Outreach
8. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
9. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
10. Neurobiological Technologies Reports Going Concern Qualification
11. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...archers at Oregon Health & Science University,s Sc...ered that the nerve cells controlling heart rate a...e critically important for proper nervous system g...t role in the prevention of Sudden Infant Death Sy...o the National Institutes of Health, SIDS is the l...
(Date:1/8/2009)...Jan. 8 Davis Vision, Inc., headqua...ivisional vice president of sales for its Northern...Il., Ehrle will contribute to Davis Vision,s natio...e a strong asset to Davis Vision,s sales managemen...vice president and chief marketing officer. "Mike ...
(Date:1/8/2009)... Susan Knapp Pinnas, a leader of p...extensive diversified healthcare,experience, has ...twork, the,company announced today. , As a...nnas will be,responsible for advancing AvMed,s ov...inciples of strong relationships and service excel...
(Date:1/8/2009)...p Call as Lighthouse International and EHE Interna..., , NEW YORK, Jan. 8 ...ign in the New Year that urges them to take care o...r Plaza and graciously donated by EHE Internationa...year-old leader in vision healthcare. It will be o...
Breaking Medicine News(10 mins):Health News:OHSU School of Dentistry team discovers new molecule in blood-pressure control system 2Health News:Davis Vision, Inc. Names Michael Ehrle Divisional Vice President of Sales 2Health News:Susan Knapp Pinnas Named AvMed Health Plans' New Senior Vice President of Network 2Health News:61 Million Americans are at Risk of Vision Loss and Don't Even Know It 2Health News:61 Million Americans are at Risk of Vision Loss and Don't Even Know It 3
... their late 30s to have children risk heartbreak, ... treats women with high-risk pregnancies at Guy's ...elated fertility problems increase after 35 and dr...he last 20 years, pregnancies in women over 35 hav...
...mpsia in pregnant women may be genetical and both ...he gene expressions that can trigger this // condi... edition of BMJ. Pre-eclampsia is a serious condit...sure and other disturbances develop in the second ...
...e better handled following discovery of a novel ch...avings. The finding has all the potential to be th...overy efforts // according to neurobiologists. Be...bjects previously associated with a drug habit can...
... Vioxx, pain killer which was found to cause the d...ioxx. Merck Pharma the manufacturers of Vioxx were...compensation // to Mrs. Ernst. Over 5 years, abou...erck stopped selling the drug in September 2004, a...
Other Medicine News:Health News:Neurobiology Provides Answers To Block Memory-Related Drug Cravings 2
(Date:1/7/2009)...ERICK, Md., Jan. 7 ImQuest Life Sc...f an IND application to the Food and Drug Administ... lead pyrimidinedione HIV inhibitor IQP-0410. ImQu...n the first quarter of 2009. IQP-0410 is a novel s...s as a nonnucleoside reverse transcriptase inhibit...
(Date:1/6/2009)...ram Expands on Successful Results from prior U.S.,...RNewswire/ -- Vital Therapies, Inc. (VTI), a devel...y announced patient enrollment has begun for a ran...l trial that will study the Extracorporeal Liver A...th Acute Liver Failure (ALF) under three protocols...
(Date:1/6/2009)...VILLE, Md., Jan. 6 Sequ...pany focused on diseases of epidemic potential, an...for the treatment of tuberculosis (TB), was the fi...d clinical program contract to Dynport Vaccine Com..., awarded by the National Institute of Allergy and...
(Date:1/5/2009)...DIEGO, Jan. 5 Cylene Pharmaceutica... clinical trial of its oral CK2 protein kinase inh...umors, Castleman,s disease, or multiple myeloma. T...rial are determination of safety, tolerance and PK...te dose for Phase II trials. In addition, multiple...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3New Therapies Could Change Organ Transplants 9981 1New Therapies Could Change Organ Transplants 9981 2New Therapies Could Change Organ Transplants 9981 3Co Pays Contribute to Drop in Preventive Care 9979 1Co Pays Contribute to Drop in Preventive Care 9979 2Co Pays Contribute to Drop in Preventive Care 9979 3Synthesis of natural molecule could lead to better anti cancer drugs 9977 1Synthesis of natural molecule could lead to better anti cancer drugs 9977 2Synthesis of natural molecule could lead to better anti cancer drugs 9977 3Synthesis of natural molecule could lead to better anti cancer drugs 9977 4Advanced Therapy Aids Stroke Patients 9975 1Advanced Therapy Aids Stroke Patients 9975 2Advanced Therapy Aids Stroke Patients 9975 3
...blished in Journal of Cell Science Shows ONCONASE ...ELD, N.J., April 05, 2007 /PRNewswire-FirstCall/ -...an researchers have,identified the pathway that ON...ished in the Journal of Cell Science (2007; 120: 1...he University of Girona in,Spain and the Universit...
...T, N.J., April 5, 2007-- Stent thrombosis,resteno...ts have,discovered that the drug-coated stents use...more of a detrimental effect on their,health than ...ecent,articles in medical journals suggest that un...inue to take blood thinners, they,could more than ...
Other Medicine Technology:Researchers Identify Intracellular Pathway of Alfacell's Onconase 2Researchers Identify Intracellular Pathway of Alfacell's Onconase 3New Cardioprotective Drug Could Provide Boost For Post-Bypass,Surgery Heart Health 2
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 8 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 7 mm.
The BacT/Alert 3D Select Link is a state of the art, automated microbial detection system that integrates blood, sterile body fluid and mycobacteria culturing. This system is useful when patient data
The Vitek is a completely automated instrument that offers Rapid results (with an average of 2 - 6 hour same day turnaround), random or batch processing and a quality control module. It is used for b
Medicine Products: